0001415889-17-000397.txt : 20170309 0001415889-17-000397.hdr.sgml : 20170309 20170309170104 ACCESSION NUMBER: 0001415889-17-000397 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170309 DATE AS OF CHANGE: 20170309 EFFECTIVENESS DATE: 20170309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medite Cancer Diagnostics, Inc. CENTRAL INDEX KEY: 0000075439 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 364296006 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-282199 FILM NUMBER: 17679168 BUSINESS ADDRESS: STREET 1: 414 NORTH ORLEANS STREET STREET 2: SUITE 502 CITY: CHICAGO STATE: IL ZIP: 60610 BUSINESS PHONE: 4078490290 MAIL ADDRESS: STREET 1: 414 NORTH ORLEANS STREET STREET 2: SUITE 502 CITY: CHICAGO STATE: IL ZIP: 60610 FORMER COMPANY: FORMER CONFORMED NAME: CytoCore Inc DATE OF NAME CHANGE: 20060815 FORMER COMPANY: FORMER CONFORMED NAME: MOLECULAR DIAGNOSTICS INC DATE OF NAME CHANGE: 20011009 FORMER COMPANY: FORMER CONFORMED NAME: AMPERSAND MEDICAL CORP DATE OF NAME CHANGE: 19990527 D 1 primary_doc.xml X0707 D LIVE 0000075439 Medite Cancer Diagnostics, Inc. 4203 SW 34th St Orlando FL FLORIDA 32811 407-996-9630 DELAWARE CYTOCORE, INC. CytoCore Inc MOLECULAR DIAGNOSTICS INC AMPERSAND MEDICAL CORP Corporation true David Eugene Patterson 4203 SW 34th St Orlando FL FLORIDA 32811 Executive Officer Director Michaela Eugene Ott 4203 SW 34th St Orlando FL FLORIDA 32811 Executive Officer Director Michael Eugene Ott 4203 SW 34th St Orlando FL FLORIDA 32811 Director John Eugene Abeles, MD 4203 SW 34th St Orlando FL FLORIDA 32811 Director William Austin Lewis IV 4203 SW 34th St Orlando FL FLORIDA 32811 Director Augusto Eugene Ocana 4203 SW 34th St Orlando FL FLORIDA 32811 Director Eric Eugene Goehausen 4203 SW 34th St Orlando FL FLORIDA 32811 Director Other Health Care $1,000,001 - $5,000,000 06b false 2016-12-29 false true true false 25000 Tripoint Global Equities, LLC 143174 None None 1450 Broadway 26th Floor New York NY NEW YORK 10018 AL ALABAMA FL FLORIDA GA GEORGIA IL ILLINOIS NY NEW YORK OH OHIO TN TENNESSEE TX TEXAS 4250000 555000 3695000 false 0 8 41625 0 Cash Commission = 7.5% Warrants Exercisable @$0.50 per share = 7.5% 0 MEDITE CANCER DIAGNOSTICS, INC. /s/ David E. Patterson David E. Patterson Chief Executive Officer 2017-03-09